5-methylurapidil has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, K; Brodde, OE; Dhein, S; Giessler, C; Pönicke, K | 1 |
| Baber, SR; Fields, AM; Hoover, JM; Ibrahim, IN; Kaye, AD | 1 |
2 other study(ies) available for 5-methylurapidil and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Inositolphosphate formation in thoracic and abdominal rat aorta following Gq/11-coupled receptor stimulation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta, Abdominal; Aorta, Thoracic; Clonidine; Endothelin Receptor Antagonists; Endothelin-1; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; In Vitro Techniques; Inositol Phosphates; Male; Muscle Contraction; Norepinephrine; Peptides, Cyclic; Piperazines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Adrenergic, alpha; Receptors, Endothelin; Receptors, Thromboxane; Vasoconstrictor Agents | 2001 |
Effects of norepinephrine on alpha-subtype receptors in the feline pulmonary vascular bed.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Angiotensin II; Animals; Cats; Clonidine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Evaluation, Preclinical; Ephedrine; Female; Injections, Intra-Arterial; Injections, Intravenous; Male; Norepinephrine; Phenylephrine; Piperazines; Pulmonary Artery; Pulmonary Circulation; Receptors, Adrenergic, alpha-1; Vascular Resistance; Vasoconstrictor Agents | 2004 |